抗体类配体
选项
-
Tarextumab (anti-NOTCH3)
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse)
- 亚型: Human IgG2
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1359940-55-8 -
Roledumab (anti-RHD)关联靶标: RHD
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 恒河猴(Rhesus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1174008-79-7 -
Sibrotuzumab (anti-FAP)关联靶标: FAP
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 216669-97-5SMILES: [Sibrotuzumab]
首页
400-620-6333


